Angelini is a privately-held international group operating in 20 countries with 6,000 employees and a turnover of 1,7 billion Euro. Started as a small pharmaceutical laboratory in Ancona, Italy, in 1919 - almost 100 years ago - today Angelini is a leading group in healthcare and wellbeing in the field of pharmaceutical and consumer products. In the Pharma sector, Angelini is strongly committed to support patients, physicians and caregivers in the fight against diseases giving foremost attention to the therapeutic areas of Pain and Inflammation, Neuroscience and Infectious Diseases. Moreover, the company boasts world-class manufacturing and marketing paths of both active ingredients and leading medical products in several market sectors. It has operations in Italy, Spain, Austria, Portugal, Poland, Czech Republic, Slovak Republic, Hungary, Romania, Germany, Bulgaria, Slovenia, Croatia, Greece, Turkey, Russia, Usa, Pakistan; strategic partnerships with international companies complete and expand the geographical areas where Angelini operates. The Angelini group is also involved in other sectors: Personal care (Fater, a joint venture between Angelini and Procter and Gamble), Machinery (Fameccanica, a joint venture between Angelini and Procter and Gamble), Perfumery (Angelini Beauty) and Wine Sector (Bertani Domains). It is a modern group, attentive to changes in the market and projected into the future, but always proud of its corporate philosophy: a growth-focused investment strategy; the steady commitment in the research and development; an in-depth knowledge of markets, business acumen and entrepreneurship.